Literature DB >> 8523198

Central nervous system disease in a child with primary Sjögren syndrome.

T Ohtsuka1, Y Saito, M Hasegawa, M Tatsuno, S Takita, M Arita, K Okuyama.   

Abstract

A 9-year-old girl had hemiparesis, and a diagnosis of primary Sjögren syndrome was made. The neurologic dysfunction was multifocal, involving both the brain and spinal cord, and was recurrent; the findings mimicked multiple sclerosis. Corticosteroid treatment during episodes of acute neurologic dysfunction appeared to be beneficial.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8523198     DOI: 10.1016/s0022-3476(95)70038-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Recurrent aseptic encephalitis in periodic fever, aphthous stomatitis, pharyngitis and adenopathy (PFAPA) syndrome.

Authors:  Richard E Frye
Journal:  Pediatr Infect Dis J       Date:  2006-05       Impact factor: 2.129

Review 2.  Anti-Sjögren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjögren's syndrome waiting to be unveiled? A case series and review of literature.

Authors:  Gaurav Kumar Mittal; Sumidha Mittal; Harleen Kaur; Shreya Rosa Stephen; Shilpa Sekhar; Sachin Sureshbabu; Pulukool Sandhya
Journal:  Rheumatol Int       Date:  2020-10-11       Impact factor: 2.631

3.  Primary Sjögren syndrome in the paediatric age: a multicentre survey.

Authors:  Rolando Cimaz; Annachiara Casadei; Carlos Rose; Jirina Bartunkova; Anna Sediva; Fernanda Falcini; Paolo Picco; Marco Taglietti; Francesco Zulian; Rebecca Ten Cate; Flavio R Sztajnbok; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Eur J Pediatr       Date:  2003-07-29       Impact factor: 3.860

4.  Treatment strategies for Sjögren's syndrome with childhood onset: a systematic review of the literature.

Authors:  Georgia Doolan; Nor Mohd Faizal; Charlene Foley; Muthana Al-Obaidi; Elizabeth C Jury; Elizabeth Price; Athimalaipet V Ramanan; Scott M Lieberman; Coziana Ciurtin
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.